2022
DOI: 10.1007/s11655-022-3721-6
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Total Saponins from Dioscorea Nipponica Makino on Monosodium Urate-Induced M1-Polarized Macrophages through Arachidonic Acid Signaling Pathway: An in vitro Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 26 publications
0
2
0
Order By: Relevance
“…In particular, COX-2 is the main source of prostacyclin (PGI2) (Deng et al, 2020). Once AA is released, it is metabolized by the PTGS isoenzymes PTGS-1 and PTGS-2 (Zhou et al, 2023). PTGS exerts two distinct, yet complementary, enzyme activities.…”
Section: Discussionmentioning
confidence: 99%
“…In particular, COX-2 is the main source of prostacyclin (PGI2) (Deng et al, 2020). Once AA is released, it is metabolized by the PTGS isoenzymes PTGS-1 and PTGS-2 (Zhou et al, 2023). PTGS exerts two distinct, yet complementary, enzyme activities.…”
Section: Discussionmentioning
confidence: 99%
“…These outcomes showcase that the EG possessed more excellent recovery of KJ function after treatment, and their pain level was also lower. The study by Zhou et al [19] shows that traditional Chinese and Western medical methods have a better promoting effect on the recovery of KJ function. In the evaluation of TCM syndrome integration, both groups of patients showed significant improvement in joint single item integration.…”
Section: Discussionmentioning
confidence: 99%
“…However, the types of arthritis treated with these targets are not completely clear. Targets, β2-adrenergic receptor (ADRB2), AHR, CRP, IRF1, prostaglandin G/H synthase 1 (PTGS1), SPP1 and other targets, exert key effects in the pathogenesis of arthritis, but role of them in the treatment of arthritis with CC has not been confirmed ( Table 3 ) ( Xu et al, 2004 ; Koskela et al, 2012 ; Ko et al, 2013 ; Li et al, 2013 ; Xue et al, 2014 ; Song et al, 2016 ; Trzybulska et al, 2018 ; Bonelli et al, 2019 ; Chu et al, 2019 ; Lin et al, 2019 ; Sun et al, 2020 ; Orecchini et al, 2020 ; Yang et al, 2020 ; Nalesso et al, 2021 ; Tang et al, 2021 ; Xu and Xu, 2021 ; Zou et al, 2021 ; Balasundaram et al, 2022 ; Cai et al, 2022 ; Liu et al, 2022 ; Wang et al, 2022 ; Zhang et al, 2022 ; Zhang et al, 2022 ; Han et al, 2022 ; Man et al, 2022 ; Nguyen et al, 2022 ; Qian et al, 2022 ; Tavallaee et al, 2022 ; Zhuang et al, 2022 ; Afnan et al, 2023 ; Baggio et al, 2023 ; Sun et al, 2023b ; Zhou et al, 2023 ; Fan et al, 2023 ; Huang et al, 2023 ; Ning et al, 2023 ; Qin et al, 2023 ; Skougaard et al, 2023 ; Tu et al, 2023 ; Xie et al, 2023 ; Yan et al, 2023 ; Yu et al, 2023 ; Zhao et al, 2023 ). We have elaborated on the role of targets such as MMP-3, IL-1β, MAPK, IL-6, ADRB2, AHR, CRP, CAV1, CXCL2, SPP1 and other targets in treating arthritis, explored the potential targets and mechanisms of CC in treating arthritis, analyzed the feasibility of CC as an anti-arthritis drug, and provided a theoretical basis for subsequent research.…”
Section: Deep Exploration Based On Potential Therapeutic Targets For ...mentioning
confidence: 99%